Markus-Frederik Bohn

Associate Professor

Danmarks Tekniske Universitet

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Markus-Frederik Bohn is an Associate Professor at Danmarks Tekniske Universitet in Denmark. His research focuses on immunology and antibody development, as evidenced by his recent publications on broadly-neutralizing antibodies, therapeutic monoclonal antibodies, and the structural insights into neutralizing antibodies against SARS-CoV-2. He is also involved in the exploration of viral protease inhibition and the development of innovative nanobody-based proteins.

Articles (11)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (11)

Tulika Tulika

Technical University of Denmark

DENMARK

View details

Andreas Hougaard Laustsen

Technical University of Denmark

DENMARK

View details

Anne Ljungars

Technical University of Denmark

DENMARK

View details

Phillip Sharp

Chief Scientific Officer

UNITED STATES

View details

Maher Abou Hachem

Technical University of Denmark

DENMARK

View details

Line Ledsgaard

Technical University of Denmark

DENMARK

View details

Esperanza Rivera-de-Torre

Technical University of Denmark

DENMARK

View details

Jiankun Lyu

Assistant Professor

Rockefeller University

UNITED STATES

View details

Tina Perica

Assistant Professor

University of Zurich

SWITZERLAND

View details

David Gordon

Assistant Professor

Emory University

UNITED STATES

View details

Shirin Ahmadi

Technical University of Denmark

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Markus-Frederik Bohn

Research Interests

Contact this professor

About

Articles (11)

Discovery of broadly‐neutralizing antibodies against brown recluse spider and Gadim scorpion sphingomyelinases using consensus toxins as antigens

Phage display assisted discovery of a pH‐dependent anti‐α‐cobratoxin antibody from a natural variable domain library

Generation of Multivalent Nanobody-Based Proteins with Improved Neutralization of Long α-Neurotoxins from Elapid Snakes

Incidence and Prevalence of Coronavirus Disease 2019 Within a Healthcare Worker Cohort During the First Year of the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic.

A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy.

Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine

The challenges with developing therapeutic monoclonal antibodies for pandemic application

Immunotargeting of Nanocrystals by SpyCatcher Conjugation of Engineered Antibodies

Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.

Structure of an affinity-matured inhibitory recombinant fab against urokinase plasminogen activator reveals basis of potency and specificity.

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

Collaborators (11)

Tulika Tulika

Andreas Hougaard Laustsen

Anne Ljungars

Phillip Sharp

Maher Abou Hachem

Line Ledsgaard

Esperanza Rivera-de-Torre

Jiankun Lyu

Tina Perica

David Gordon

Shirin Ahmadi

Make your next move.